Lactobacillus paracasei strain
US-12152232-B2 · Nov 26, 2024 · US
US12570964B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12570964-B2 |
| Application number | US-202418611058-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 20, 2024 |
| Priority date | Jul 15, 2016 |
| Publication date | Mar 10, 2026 |
| Grant date | Mar 10, 2026 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention discloses a bacterium and an obtaining method and application thereof. The bacterium has a property of coproducing 1,3-propanediol and D-lactic acid. Further, the bacterium is Klebsiella oxytoca , including Klebsiella oxytoca PDL-5 CCTCC M 2016185. The obtaining method of the bacterium may be to obtain the bacterium by directly screening wild bacteria that satisfy conditions from the environment or performing gene engineering modification to wild bacteria. The present invention has the advantages that the bacteria can coproduce 1,3-propanediol and D-lactic acid through fermentation, the molar conversion rate and the concentration of the two products are very high, the types of byproducts are few, the concentration is low, the product extraction process is simplified, the high-efficiency biological production of 1,3-propanediol and D-lactic acid can be realized, and the industrial application prospect is very great.
Opening claim text (preview).
The invention claimed is: 1 . A method for constructing an artificial bacterium including a step of introducing a glycerol dehydratase coding gene dhaB and a 1,3-PD oxidordeuctase coding gene dhaT into a wild type bacterium by genetic engineering method, wherein the method further includes a step of introducing a gene dldhBc of D-lactate dehydrogenase into the wild type bacterium by a genetic engineering method; wherein the wild type bacterium is Klebsiella oxytoca PDL-0 and wherein the Klebsiella oxytoca PDL-0 was collected in China Center for Type Culture Collection on Apr. 8, 2016, and the collection registration number is CCTCC M 2016184. 2 . The method according to claim 1 , wherein the genes dhaB and dhaT are from Klebsiella oxytoca. 3 . The method according to claim 1 , wherein the gene dldh Bc is from Bacillus coagulans. 4 . The method according to claim 1 , wherein the genes dhaB and dhaT are introduced into the wild type bacterium by plasmid vectors. 5 . The method according to claim 1 , wherein the genes dhaB and dhaT are introduced into the wild type bacterium by shuttle plasmids so as to be integrated into the genome of the wild type bacterium. 6 . The method according to claim 1 , wherein the gene dldh Bc is introduced into the wild type bacterium by plasmid vectors. 7 . The method according to claim 1 , wherein the gene dldh Bc is introduced into the wild type bacterium by shuttle plasmids so as to be integrated into the genome of the wild type bacterium. 8 . The method according to claim 7 , wherein the gene dldh Bc is integrated into a position of D-lactate dehydrogenase locus to replace the D-lactate dehydrogenase gene of the wild type bacterium. 9 . The method according to claim 1 , wherein the gene dldh Bc is codon optimized to be applicable for the wild type bacterium. 10 . The method according to claim 1 , wherein the Klebsiella oxytoca PDL-0 is modified to have defects of genes budA and budB by homologous recombination method, or the Klebsiella oxytoca PDL-0 is modified to have defects of genes budA, budB and adhE by homologous recombination method; or the Klebsiella oxytoca PDL-0 is modified to have defects of genes budA, budB, adhE and ackA-pta by homologous recombination method; or the Klebsiella oxytoca PDL-0 is modified to have defects of genes budA, budB, adhE, ackA-pta and poxB by homologous recombination method; or the Klebsiella oxytoca PDL-0 is modified to have defects of genes budA, budB, adhE, ackA-pta, poxB and frdA by homologous recombination method, wherein budA represents α-acetolactate decarboxylase gene, budB represents α-acetolactate synthetase gene, adhE represents aldehyde dehydrogenase gene, ackA-pta represents acetokinase and acetyl phosphate transferase gene, poxB represents pyruvate oxidase gene, and frdA represents fumarate reductase gene. 11 . The method according to claim 10 , wherein a DNA sequence of the budA is as shown in SEQ ID NO:1; and/or a DNA sequence of the budB is as shown in SEQ ID NO: 2; and/or a DNA sequence of the adhE is as shown in SEQ ID NO:3; and/or a DNA sequence of the ackA-pta is as shown in SEQ ID NO:4; and/or a DNA sequence of the poxB is as shown in SEQ ID NO:5; and/or a DNA sequence of the frdA is as shown in SEQ ID NO:6.
Lactobacillus plantarum · CPC title
Klebsiella · CPC title
Bacterial isolates · CPC title
Lyases (4.) · CPC title
transferring aldehyde or ketonic groups (2.2) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.